Skip to main content
. 2012 Sep 6;7(9):e44580. doi: 10.1371/journal.pone.0044580

Figure 3. Exogenous TGF-β2 suppresses IFN-λ1/IL-29 release from virally infected (A) (n = 10) or poly IC (n = 4) exposed (B) PBEC cultures from non-asthmatic donors.

Figure 3

IFNλ1/IL-29 protein levels were measured by ELISA from RV-infected or poly IC exposed PBECs treated with TGF-β2 as described in Figure 2. Median (IQR) IFN-λ1 release  = 3896 (2766) and 4932 (4941) pg/ml for cells treated with 1 or 10 µg/ml Poly IC, respectively.